T-loop and telomere end structure: telomere mechanism

Two caveats govern every page on this site. (1) Telomere length is a contested aging biomarker — it is measured differently by different methods, varies between tissues, and "longer" is not straightforwardly "healthier"; changing a telomere-length or telomerase-activity number in a trial is not the same as slowing human aging. (2) Activating telomerase is not risk-free — telomerase is silenced in most somatic cells and reactivated in most cancers, so its activation raises an unresolved cancer-risk question. Tellingly, the only FDA-approved telomerase drug — imetelstat (RYTELO, 2024) — inhibits telomerase to treat cancer (lower-risk MDS), the opposite direction from the anti-aging "activation" narrative.

Definition

Category: End-protection structure

Also known as: t-loop, telomere loop, D-loop

The T-loop is a lasso-like structure in which the single-stranded 3' telomeric overhang folds back and invades the upstream double-stranded telomeric repeats, tucking the chromosome end away. Together with shelterin, the T-loop hides the natural end from the DNA-damage response so it is not processed as a break.

Key points

The T-loop is a physical solution to the end-protection problem: by sequestering the end, it prevents inappropriate DNA-repair and end-to-end fusions.
T-loop formation and unwinding are regulated by shelterin (notably TRF2) and must be opened to allow replication and telomerase access.
This is a structural mechanism node; no intervention on this site directly targets the T-loop.

Sourcing

Standard telomere-structure reviews (Griffith & de Lange, T-loop). Review-level description.

Reference synthesis (tier 4); verification: review_level_2026-07-12.